SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-167276
Filing Date
2014-04-29
Accepted
2014-04-29 16:24:23
Documents
6
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d695813ddefa14a.htm DEFA14A 44814
2 GRAPHIC g695813pcb_pg01.jpg GRAPHIC 1777
3 GRAPHIC g695813pcb_pg02a.jpg GRAPHIC 2670
4 GRAPHIC g695813pcb_pg02b.jpg GRAPHIC 1804
5 GRAPHIC g695813pcb_pg03.jpg GRAPHIC 1801
6 GRAPHIC g695813pcb_pg04.jpg GRAPHIC 1799
  Complete submission text file 0001193125-14-167276.txt   60145
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35952 | Film No.: 14794249
SIC: 2834 Pharmaceutical Preparations